The Holder of Common Stock Purchase Warrants of InMed Pharmaceuticals Inc. issued February 12, 2021InMed Pharmaceuticals Inc. • March 22nd, 2022 • Pharmaceutical preparations
InMed Pharmaceuticals Inc. (the “Company”) desires to amend (i) the Securities Purchase Agreement, dated as of February 5, 2021, by and among the Company and the purchasers signatory thereto pursuant to which the Company issued, among other securities, the Warrants (as defined below) (the “Purchase Agreement”) and (ii) the Common Stock Purchase Warrant issued February 12, 2021, by the Company and the purchaser(s) signatory thereto pursuant to which the Company issued the Warrants (as defined below) (the “Warrant Agreement”).
